Shapira & Stein Home Healthcare Agency | |
4741 Laurel Canyon Blvd, Suite 208, Valley Village, California 91607 | |
(818) 985-6800 | |
Name | Shapira & Stein Home Healthcare Agency |
---|---|
Location | 4741 Laurel Canyon Blvd, Suite 208, Valley Village, California |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 59213 |
Ownership Type | Proprietary |
Service Area Zip Codes | 90001, 90002, 90003, 90004, 90008, 90011, 90012, 90013, 90016, 90022, 90027, 90028, 90033, 90034, 90035, 90038, 90044, 90045, 90046, 90047, 90048, 90049, 90056, 90065, 90066, 90069, 90077, 90220, 90265, 90274, 90291, 90292, 90401, 90402, 90404, 90405, 90640, 90814, 91104, 91303, 91304, 91316, 91331, 91335, 91344, 91350, 91402, 91403, 91411, 91601, 91605, 91606, 91607, 91754, 92807, 93063, 93534, 93535 |
NPI Number | 1679724223 |
Organization Name | SHAPIRA AND STEIN, INC. |
Doing Business As | SHAPIRA & STEIN HOME HEALTH CARE AGENCY |
Address | 4741 Laurel Canyon Blvd, Suite 208, Valley Village, CA 91607 |
Phone Number | 818-985-6800 |
News Archive
The majority of citizens in developed countries should not be concerned by potential harm from exercise but rather by the lack of exercise in their lives, according to a clinical perspective published today in the Journal of the American College of Cardiology from the ACC Sports and Exercise Cardiology Leadership Council.
Point-of-care testing is a rapidly growing sector, bringing medical testing from central laboratories to where the patient is receiving care.
Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced results from the remede System Pilot Study during the Heart Failure Society of America Late Breaking Scientific Session in Orlando. Dr. William T. Abraham of The Ohio State University Wexner Medical Center in Columbus presented the results for the first and only implantable device for respiratory rhythm management to treat central sleep apnea.
DAMAGING a cell's nucleolus could destroy cancer cells by increasing levels of the most important tumour prevention protein, p53, reveals research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, today.
› Verified 7 days ago
Quality Rating: |
News Archive
The majority of citizens in developed countries should not be concerned by potential harm from exercise but rather by the lack of exercise in their lives, according to a clinical perspective published today in the Journal of the American College of Cardiology from the ACC Sports and Exercise Cardiology Leadership Council.
Point-of-care testing is a rapidly growing sector, bringing medical testing from central laboratories to where the patient is receiving care.
Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced results from the remede System Pilot Study during the Heart Failure Society of America Late Breaking Scientific Session in Orlando. Dr. William T. Abraham of The Ohio State University Wexner Medical Center in Columbus presented the results for the first and only implantable device for respiratory rhythm management to treat central sleep apnea.
DAMAGING a cell's nucleolus could destroy cancer cells by increasing levels of the most important tumour prevention protein, p53, reveals research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, today.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 93.6 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 96.8 | 98.6 |
How often the home health team checked patients’ risk of falling | 99 | 99.6 |
How often the home health team checked patients for depression | 96.8 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 45.5 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 45.2 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
The majority of citizens in developed countries should not be concerned by potential harm from exercise but rather by the lack of exercise in their lives, according to a clinical perspective published today in the Journal of the American College of Cardiology from the ACC Sports and Exercise Cardiology Leadership Council.
Point-of-care testing is a rapidly growing sector, bringing medical testing from central laboratories to where the patient is receiving care.
Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced results from the remede System Pilot Study during the Heart Failure Society of America Late Breaking Scientific Session in Orlando. Dr. William T. Abraham of The Ohio State University Wexner Medical Center in Columbus presented the results for the first and only implantable device for respiratory rhythm management to treat central sleep apnea.
DAMAGING a cell's nucleolus could destroy cancer cells by increasing levels of the most important tumour prevention protein, p53, reveals research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, today.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 85.6 | 79.6 |
How often patients got better at getting in and out of bed | 76.6 | 81.1 |
How often patients got better at bathing | 79.9 | 82.3 |
How often patients’ breathing improved | 48.7 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 49.3 | 75 |
How often home health patients had to be admitted to the hospital | 11.2 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 7.8 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 96.7 | 94 |
News Archive
The majority of citizens in developed countries should not be concerned by potential harm from exercise but rather by the lack of exercise in their lives, according to a clinical perspective published today in the Journal of the American College of Cardiology from the ACC Sports and Exercise Cardiology Leadership Council.
Point-of-care testing is a rapidly growing sector, bringing medical testing from central laboratories to where the patient is receiving care.
Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced results from the remede System Pilot Study during the Heart Failure Society of America Late Breaking Scientific Session in Orlando. Dr. William T. Abraham of The Ohio State University Wexner Medical Center in Columbus presented the results for the first and only implantable device for respiratory rhythm management to treat central sleep apnea.
DAMAGING a cell's nucleolus could destroy cancer cells by increasing levels of the most important tumour prevention protein, p53, reveals research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, today.
› Verified 7 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | Not Available |
Health team communicated well with them | Not Available |
Health team discussed medicines, pain, and home safety | Not Available |
How patients rated overall care from agency | Not Available |
News Archive
The majority of citizens in developed countries should not be concerned by potential harm from exercise but rather by the lack of exercise in their lives, according to a clinical perspective published today in the Journal of the American College of Cardiology from the ACC Sports and Exercise Cardiology Leadership Council.
Point-of-care testing is a rapidly growing sector, bringing medical testing from central laboratories to where the patient is receiving care.
Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced results from the remede System Pilot Study during the Heart Failure Society of America Late Breaking Scientific Session in Orlando. Dr. William T. Abraham of The Ohio State University Wexner Medical Center in Columbus presented the results for the first and only implantable device for respiratory rhythm management to treat central sleep apnea.
DAMAGING a cell's nucleolus could destroy cancer cells by increasing levels of the most important tumour prevention protein, p53, reveals research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, today.
› Verified 7 days ago
The patient survey data of Shapira & Stein Home Healthcare Agency is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 87 | 88 |
Percent of patients who reported that their home health team communicated well with them | 94 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 93 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 87 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 81 | 78 |
News Archive
The majority of citizens in developed countries should not be concerned by potential harm from exercise but rather by the lack of exercise in their lives, according to a clinical perspective published today in the Journal of the American College of Cardiology from the ACC Sports and Exercise Cardiology Leadership Council.
Point-of-care testing is a rapidly growing sector, bringing medical testing from central laboratories to where the patient is receiving care.
Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced results from the remede System Pilot Study during the Heart Failure Society of America Late Breaking Scientific Session in Orlando. Dr. William T. Abraham of The Ohio State University Wexner Medical Center in Columbus presented the results for the first and only implantable device for respiratory rhythm management to treat central sleep apnea.
DAMAGING a cell's nucleolus could destroy cancer cells by increasing levels of the most important tumour prevention protein, p53, reveals research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, today.
› Verified 7 days ago
Premium Care Services, Inc Location: 5301 Laurel Canyon Blvd, Suite 201, Valley Village, California 91607 Ratings: Phone: (818) 358-4334 | |
Valley Village Home Health Inc Location: 12722 Riverside Drive, Suite 207, Valley Village, California 91607 Ratings: Phone: (818) 763-2063 | |
Meraki Home Health Care Inc Location: 5301 Laurel Canyon Blvd, Suite 211, Valley Village, California 91607 Ratings: Phone: (818) 506-3158 | |
Top Choice Home Health, Inc Location: 5301 Laurel Canyon Blvd, Unit 244, Valley Village, California 91607 Ratings: NA Phone: (818) 210-0300 | |
Metropolitan Home Health Location: 12135 Riverside Drive, Valley Village, California 91607 Ratings: Phone: (818) 508-5801 | |
Med Care, Inc Location: 12722 Riverside Dr, Ste 101, Valley Village, California 91607 Ratings: Phone: (818) 336-9811 |